(Q46194899)

English

Diabetes and aspirin: beware of underpowered negative trials

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19088728

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19088728

editorial

0 references

title

Diabetes and aspirin: beware of underpowered negative trials (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19088728

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19088728

1 reference

Michael E Farkouh

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19088728

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19088728

Valentin Fuster

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19088728

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19088728

publication date

1 January 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19088728

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19088728

published in

Nature Clinical Practice Cardiovascular Medicine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19088728

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19088728

volume

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19088728

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19088728

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19088728

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19088728

page(s)

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19088728

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19088728

cites work

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19088728

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19088728

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NCPCARDIO1433

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19088728

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19088728

PubMed publication ID

19088728

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19088728

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19088728

(Q46194899)

Diabetes and aspirin: beware of underpowered negative trials

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)